Oxford Global Conferences are proud to present our 11th Annual Proteins & Antibodies Congress, 16-17 April 2018, London, UK with our co-located 5th Annual Peptides Congress and 5th Annual Biosimilars & Biobetters Congress. Across the two days, over 450 proteins, antibodies, peptides and biosimilars & biobetters attendees representing global pharmaceutical organizations, leading biotech companies and internationally renowned academic institutions.
Over 50 case studies, presentations and panel discussions focused on the key issues in protein and antibody engineering & development, protein & antibody biotherapeutics as well as biotherapeutics manufacturing and chemistry.
Including 5 interactive streams:
• Protein Engineering, Design & Selection
• Biotherapeutics: Manufacturing, Chemistry, Analytics and Control
• Antibody Engineering, Design & Development
• Cloning, Expressions, Purification & Analytics
• Protein & Antibody Biotherapeutics
Download Agenda: http://bit.ly/2iqjUH3
Free Live Webinars
Protein & Antibody Biotherapeutics – Manufacturing & Developability Assessment
Hosted by David Gervais, Head of Product Development, Porton Biopharma and Thorsten Lorenz, Group Head Developability Assessment 1, Novartis
Register for Free Today: http://bit.ly/2g4nJRl
Antibody Biotherapeutics: Current Technologies And Recent Therapeutic Success
Hosted by David Mantus, Chief Development Officer, Arsanis and Pallavi Tawde, Single B Cell Cloning Platform Leader, Bristol-Myers Squibb
Register for Free Today: http://bit.ly/2wnmDqw
For further information regarding prices and possible discounts, please contact Danielle Dalby on firstname.lastname@example.org or call +44 (0)1865 248 455.